News from the 10th Expert Meeting of the Editorial Board of PCSK9 Education and Research Forum
Treatment Guidelines: Now and the Future
Professor Henry Ginsberg (University of Columbia, New York, USA): The 2018 AHA/ACC Treatment guidelines: Key learnings
Professor Børge Nordestgaard (University of Copenhagen, Denmark): Lipoprotein(a): a therapeutic target in guidelines?
Surfing the PCSK9 wave of discovery
Novel approaches to PCSK9 inhibition, including inclisiran and LIB003, have made the news. Prof Derick Raal (University of Witwatersrand, Johannesburg, South Africa) gives his perspective on the newest ‘PCSK9 kids on the block’ amidst the wave of PCSK9 discovery.
Read the report
Watch the video